ESCMID is part of the VALUE-Dx project, a European Public-Private Partnership to fight antimicrobial resistance through diagnostics.

This unique multidisciplinary consortium involves clinicians, microbiologists, health economists, social scientists, and industry, to help build the medical and economic case for rapid diagnostics as a public good in the fight against antibiotic resistance.

You can find an overview of the project here.

Latest news about the activities of the work packages are published here.


VALUE-Dx E-learning platform

The open access e-learning platform from VALUE-Dx hosts educational material (presentations, documents, handouts) to support the adoption of diagnostics in community care settings.

Find here the latest materials!

New Value-Dx Graphic

They have released a new graphic just in time for WAAW 2021 under the theme of Spread Awareness, Stop Resistance. It highlights the ever continuing arms race of evolution between humans and bacteria as they develop antimicrobial resistance. Furthermore, the inappropriate use of antibiotics accelerates antimicrobial resistance which means that even as humans evolve, superbugs will always be faster. We are reminded to only take antibiotics under proper medical supervision.


Value-Dx campaign page

WAAW Campaign 2020

World Antimicrobial Awareness Week (WAAW) is a WHO initiative aiming to increase awareness of global antimicrobial resistance (AMR) and to encourage best practices among the general public, health workers and policy makers to avoid the further emergence and spread of drug-resistant infections.


This year the WAAW 2020 campaign theme is is “United to preserve antimicrobials” and is happening from November 18 - 24.


ESCMID is a proud participant in Value-Dx and stand with them in participating in this great initiative. You can find Value-Dx campaign material and a link to the official WHO campaign down below.

Value-Dx campaign page

WHO WAAW 2020 campaign page

New Flyer on ADEQUATE

ADEQUATE  is a randomized controlled trial of Rapid Syndromic Diagnostic testing for enhancing the quality of antibiotic prescribing for community acquired acute respiratory tract infection (CA-ARTI) in Emergency Rooms in Europe.


There is a need to assess the impact of rapid syndromic diagnostic testing in patients with CA-ARTI presenting to Emergency Rooms on clinical decision making related to hospitalization and antibiotics prescribing. At the same time it must be determined whether the decisions guided by the rapid syndromic diagnostic testing results do not compromise patient safety.

Here you can find the new flyer outlining the criteria for adult site selection for ADEQUATE

WAAW Campaign 2019

Since 2019, VALUE-Dx is participating to the World Antibiotic Awareness Week, the campaign held in November first initiated by WHO with the purpose of raising global awareness on proper handling of antibiotics and sharing good practices.


You can find more information about the initiatives carried out during last WAAW campaign by VALUE-Dx and its partners here.